Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Journal of Acquired Immune Deficiency Syndromes (1999)|August 8, 2025
Brief Report: Switching to Long-Acting CAB/RPV: Data From an Italian Monocentric CohortMaddalena Matone, Marco Piscaglia, Andrea Giacomelli, et al.
AIDS Research and Human Retroviruses|December 7, 2020
Short Communication: Comparing Lamivudine+Dolutegravir and Bictegravir/Emtricitabine/Tenofovir Alafenamide as Switch Strategies: Preliminary Results from Clinical PracticeGianmaria Baldin, Arturo Ciccullo, Francesca Lombardi, et al.
Travel Medicine and Infectious Disease|June 23, 2022
New challenges in human monkeypox outside Africa: A review and case report from ItalyDavide Mileto, Agostino Riva, Miriam Cutrera, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 9, 2022
Isolation of viable monkeypox virus from anal and urethral swabs, Italy, May to July 2022Davide Moschese, Giacomo Pozza, Davide Mileto, et al.
Sexual Health|October 29, 2025
Effect of amoxicillin exposure before penicillin administration on Jarisch-Herxheimer incidence in people with early syphilis: a retrospective studyFrancesco Caruso, Samuel Lazzarin, Francesco Petri, et al.
AIDS and Behavior|March 25, 2024
Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections AcquisitionRoberto Rossotti, Alessandro Tavelli, Daniele Calzavara, et al.
Le Infezioni in Medicina|December 18, 2018
Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: preliminary results from clinical practiceArturo Ciccullo, Alessandro D'Avino, Anna Pia Lassandro, et al.
Pathogens (Basel, Switzerland)|June 28, 2023
Detection of Asymptomatic Mpox Carriers among High-Ri Men Who Have Sex with Men: A Prospective AnalysisRoberto Rossotti, Daniele Calzavara, Massimo Cernuschi, et al.
The Journal of Antimicrobial Chemotherapy|January 30, 2026
Impact of sex, age and body composition on rilpivirine and cabotegravir trough concentrations in people with HIV receiving long-acting injectable antiretroviral therapyMaria Vittoria Cossu, Dario Cattaneo, Sara Soloperto, et al.
Sexually Transmitted Infections|March 24, 2026
Medical and psychological needs for injectable long-acting cabotegravir as pre-exposure prophylaxisRoberto Rossotti, Alessandra Bianchi, Alessandro Tavelli, et al.
Pageof 6